Compare Merck Tbk. (MERK) vs Multi Indocitra Tbk. (MICE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck Tbk. vs Multi Indocitra Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Multi Indocitra Tbk. trades at Rp530 (market cap 303B, 154.1K 24h volume). The key difference: Merck Tbk. is far larger — about 5.6× Multi Indocitra Tbk.'s market cap, and Multi Indocitra Tbk. is more actively traded (154.1K versus 37.6K). Which is the better fit depends on your goals.
| MERK | MICE | |
|---|---|---|
Market Cap | 1.7T | 303B |
Volume | 37.6K | 154.1K |
Lot | 376 | 1.54K |
Turnover | 144.47M | 81.24M |
Average Price | 3,842.23 | 527.17 |
Value | 144.47M | 81.24M |
Indicative Equilibrium Price | 3,840 | — |
Indicative Equilibrium Volume | 7 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →About Multi Indocitra Tbk.
PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Read more on MICE →
